Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes (Q48111094)

8 February 2018

http://europepmc.org/abstract/MED/28304146

title

Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes (English)

1 reference

8 February 2018

http://europepmc.org/abstract/MED/28304146

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Manisha Garg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Husam Ghanim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Nitesh D Kuhadiya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kelly Green

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jeanne Hejna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sanaa Abuaysheh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Barrett Torre

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Antoine Makdissi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ajay Chaudhuri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

17 March 2017

1 reference

8 February 2018

http://europepmc.org/abstract/MED/28304146

published in

Diabetes, Obesity and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

1306-1311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

Liraglutide as additional treatment for type 1 diabetes.

1 June 2020

cites work

1 reference

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes

21 January 2018

1 reference

Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.

21 January 2018

1 reference

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus

21 January 2018

1 reference

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks

21 January 2018

1 reference

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.

21 January 2018

1 reference

Overview of the diagnosis and management of diabetic ketoacidosis

21 January 2018

1 reference

Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling

21 January 2018

1 reference

Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes

21 January 2018

1 reference

Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function

21 January 2018

1 reference

Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges

21 January 2018

1 reference

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.

21 January 2018

1 reference

Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study

21 January 2018

1 reference

The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome.

21 January 2018

1 reference

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers

21 January 2018

1 reference

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.

21 January 2018

1 reference

Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28304146%20AND%20SRC:MED&resulttype=core&format=json